Moukheibir Catherine
- SEC CIK
- 0001772130
No open-market purchases or sales filed in the past year.
Current role at each company
- MLTX MoonLake ImmunotherapeuticsDirectoras of Jun 18, 2026
- IRWD Ironwood Pharmaceuticals IncDirectoras of Jun 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Moukheibir Catherine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MLTX MoonLake Immunotherapeutics
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 (view filing) | Jul 3 | 4 days | Moukheibir CatherineDirector | SSaleClass A ordinary shares, par value $0.0001 per share | −23.5K | $48.79 | −$1.15M | −100.0%0 after |
IRWD Ironwood Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 (view filing) | Jun 6-7 | 4 days | Moukheibir CatherineDirector | SSaleClass A Common Stock | −80.0K | $6.47 | −$517.7K | −62.2%48.6K after | 2 lots |